CVS Health Foundation and AACP continue program to reduce barriers for student pharmacists
Scholarships will help reduce financial barriers for student pharmacists.
Scholarships will help reduce financial barriers for student pharmacists.
Saves more than $800 million over 10 years; brings lower-cost medicines to patients soone
Amid growing anxieties, nearly 80% of shoppers feel in control of grocery spending, signaling resilience during economic uncertainty.
Retailers are encouraged to merchandise dietary support items near pharmacies, enhance digital shopping tools, and adapt packaging to highlight nutritional benefits clearly.
“We look forward to working collaboratively with FDA and other stakeholders on this important scientific and regulatory paradigm shift,” says the CHPA.
“The pullback we’ve seen the past few months comes despite strong economic fundamentals. A major factor appears to be driven by the uncertainty caused by tariffs,” NRF President and CEO Matthew Shay said.
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
Affordable family fun returns and new hospitality experience off 17th green debuts.
It’s uncertain whether tariffs will influence more companies to make more drugs in the U.S. like Trump is hoping for, some experts said.
Kool-Aid is introducing a limited-edition flavor pack, the first new offering from the brand in over five years.
The secret to this treat? A thick and creamy peanut butter filling that delivers Reese's iconic taste. The snack aisle just got a lot more awesome.
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of Schizophrenia in adults and adolescents (13 to 17 years) and other depressive episodes.
“We urge Congress to move quickly to approve this integral measure.”
Amneal’s donations will be directed toward programs that offer funding support for out-of-pocket costs—including copayments, coinsurance, and deductibles—for FDA-approved Parkinson’s medications.